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Abstract
Background: We have developed a gene expression assay (Whole-Genome DASLH), capable of generating whole-genome
gene expression profiles from degraded samples such as formalin-fixed, paraffin-embedded (FFPE) specimens.
Methodology/Principal Findings: We demonstrated a similar level of sensitivity in gene detection between matched fresh-
frozen (FF) and FFPE samples, with the number and overlap of probes detected in the FFPE samples being approximately
88% and 95% of that in the corresponding FF samples, respectively; 74% of the differentially expressed probes overlapped
between the FF and FFPE pairs. The WG-DASL assay is also able to detect 1.3–1.5 and 1.5–2 -fold changes in intact and FFPE
samples, respectively. The dynamic range for the assay is ,3 logs. Comparing the WG-DASL assay with an in vitro
transcription-based labeling method yielded fold-change correlations of R
2 ,0.83, while fold-change comparisons with
quantitative RT-PCR assays yielded R
2,0.86 and R
2,0.55 for intact and FFPE samples, respectively. Additionally, the WG-
DASL assay yielded high self-correlations (R
2.0.98) with low intact RNA inputs ranging from 1 ng to 100 ng; reproducible
expression profiles were also obtained with 250 pg total RNA (R
2,0.92), with ,71% of the probes detected in 100 ng total
RNA also detected at the 250 pg level. When FFPE samples were assayed, 1 ng total RNA yielded self-correlations of
R
2,0.80, while still maintaining a correlation of R
2,0.75 with standard FFPE inputs (200 ng).
Conclusions/Significance: Taken together, these results show that WG-DASL assay provides a reliable platform for genome-
wide expression profiling in archived materials. It also possesses utility within clinical settings where only limited quantities
of samples may be available (e.g. microdissected material) or when minimally invasive procedures are performed (e.g.
biopsied specimens).
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Introduction
Formalin-fixed, paraffin-embedded (FFPE) tissues represent an
invaluable resource for cancer research, as they are the most
widely available material for which patient outcomes are known.
There were over 300 million archived cancer tissue samples in the
United States in 1999, with more samples accumulating at a rate
of over 20 million per year [1]. The ability to perform gene
expression profiling in these samples will enable both prospective
and retrospective studies, and should greatly facilitate research in
correlating expression profiles with clinical outcomes [2]. Howev-
er, formalin fixation is known to render adenosine residues
particularly prone to chemical modifications such as methylene
dimerization and mono-methylolation [3] and generate degraded
RNA fragments (up to 50% of which may not contain a poly-A
tract) [4]. The degradation and chemical modification of RNA
during tissue fixation and storage present challenges when
applying conventional microarray technologies [3,5–8].
To overcome the technical limitations to microarray-based
analyses of FFPE samples, we previously developed a sensitive
and reproducible gene expression profiling assay, DASL (cDNA-
mediated annealing, selection, extension and ligation), for parallel
analysis of hundreds of genes with highly degraded RNA samples
[9–11]. The DASL assay incorporates random priming during
cDNA synthesis, and therefore does not depend solely on poly-
A/oligo-dT based priming. In addition, the assay requires a
relatively short target sequence of about 50 nucleotides for
query oligonucleotide annealing; thus, it can effectively quantify
degraded RNA samples. While most other technologies rely on
multiple rounds of random priming for sample amplification and
labeling [3], DASL only generates first strand cDNA that
minimizes variation that arises during the random priming. This
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archived FFPE tumor samples, some of which have been in
storage for as long as 24 years [12] and for which, in many cases,
little or no tissue handling and fixation details are known,
including colon [10,11], breast [10,11,13–16], lung [11,14],
prostate [11,12,17–19], bladder [16], and liver [20] cancer. While
all of these applications clearly demonstrated the utility of the
technology for identification and validation of tissue and cancer-
specific markers, the DASL assay was limited by the number of
genes that could be profiled simultaneously (up to 1536 targets).
In this study, we extended the assay to include all 24K well-
annotated RefSeq genes. We provide here a comprehensive
characterization of the assay sensitivity and quantitative perfor-
mance on FFPE tissues. This opens up new avenues for large-scale
discovery, validation, and clinical applications of mRNA biomark-
ers in human diseases.
Results
Assay Reproducibility
To assess the reproducibility of the WG-DASL assay we initially
used inputs of 200 ng total RNA extracted from six different
ovarian tumor FFPE tissues. The samples were labeled and
hybridized as described in the Materials and Methods section.
Each sample was assayed twice and the correlation was assessed
for each FFPE tissue. Raw intensity scatterplots of a representative
example, yielded a correlation coefficient R
2=0.988 and a slope
of approximately 45 degrees (Fig. 1A). When probe detection
concordance rates (Detection p-value ,0.01) were calculated
between replicates, a high degree of overlap was obtained, with an
average probe concordance rate of 94.6%. Detailed data for two
representative FFPE samples are presented in Table 1.
Profiling of two intact (100 ng) and artificially degraded
(200 ng; 95uC for 30 min) cancer cell line RNAs (Raji and
MCF-7) also yielded highly reproducible expression profiles, with
an average correlation of R
2,0.989 (Fig. 1B, Table 2) and 0.985
(Fig. 1C, Table 2) for the intact and artificially degraded samples,
respectively. Average probe concordance rates between replicates
were 97.9% and 95.9% for the intact and artificially degraded
samples, respectively (Table 2). Despite the relatively high degree
of overlap of detected probes between the intact and the
corresponding artificially degraded samples (,93.9%), direct
comparisons of the raw intensities between intact and artificially
degraded samples yielded correlations of R
2,0.71. This is thought
to be due to different degradation rates and/or secondary
structures of mRNAs between intact and degraded samples
[4,21]. Therefore we performed fold-change comparisons in
which intact sample pairs were compared to their corresponding
degraded samples pairs. Using this approach highly correlated
data were obtained, with an average R
2=0.91 (Fig. 1D). This
result suggests that our method can faithfully detect differentially
expressed genes in intact as well as degraded samples.
Comparison between Fresh-Frozen and FFPE Samples
We next assessed the performance of the WG-DASL assay in
matched pairs of fresh frozen (FF) and FFPE samples, using RNAs
derived from normal adjacent tissue (NAT) and tumor (TUM)
lung tissue. We obtained a high degree of sensitivity, with the
number of detected transcripts in both the NAT and TUM FFPE
samples approximately 90% of that detected in the corresponding
FF samples (Fig. 2A). Moreover, the overlap of the detected
transcripts was also high, with 94.2% (14188/15064; NAT)
and 96.3% (14066/14610; TUM) of the FFPE transcripts also
detected in the corresponding FF sample (Fig. 2B). Direct intensity
comparisons between matched FF and FFPE samples yielded
average correlations of R
2,0.62; fold-change comparisons of
several thousand detected transcripts between paired FF and FFPE
samples were higher (average R
2,0.70, Fig. 2C), with a slope
approximating 45 degrees and no significant compression or
expansion observed for the log fold-change ratios. We also
generated lists of differentially expressed transcripts between the
TUM and NAT samples for both FF and FFPE tissues and then
determined the extent of the overlap between the two differentially
expressed transcript lists. With a false discovery rate (FDR) of
,5%, approximately 74% (4793/6473) of the transcripts
identified in the FFPE comparison also overlapped with those
identified in the FF comparison (Fig. 2D). Similar overlapping
results were obtained at a more stringent FDR (,1%) (Fig. S1).
Fold-Change Detection and Dynamic Range
To further characterize the sensitivity of the WG-DASL assay,
we designed an experiment to evaluate the ability of the assay to
discriminate among different RNA mixtures. Total RNAs from
Raji and MCF-7 cells were mixed in the following ratios: 100/0,
90/10, 75/25, 67/33, 50/50, 33/67, 25/75, 10/90 and 0/100%
(corresponding to 1.0, 1.1, 1.3, 1.5, 2.0, 3.0, 4.0 and 10.0 fold-
change respectively), with six replicates performed for each
mixture and having a combined input of 100 ng in each case.
Unsupervised hierarchical clustering revealed that the assay was
able to accurately recapitulate the expected relationships among
the different mixed samples (Fig. 3A).
For a more rigorous analysis, we next selected a set of probes
that were specific for the Raji cell line such that the detection p-
value ,0.01 for Raji, but .0.1 for MCF-7. Using these thresholds
a set of 433 Raji-specific probes were obtained. The average signal
intensities for this probe set in each mixture were calculated and
then compared to that obtained for the 100% Raji RNA sample.
With 98% of the Raji-specific probes detected in the 25–33%
Raji/MCF-7 mixtures, the WG-DASL assay therefore is capable
of detecting 1.3–1.5-fold changes in intact samples (Fig. 3B).
We next performed a similar experiment to assess the fold-
change detection capabilities of the WG-DASL assay using FFPE
samples. For this experiment RNAs from two different FFPE
samples (DFCI #121 and DFCI #123) were mixed in the
following ratios: 100/0, 75/25, 67/33, 50/50, 33/67, 25/75 and
0/100% (corresponding to 1.0, 1.3, 1.5, 2.0, 3.0 and 4.0 fold-
change respectively), with six replicates performed for each
mixture and having a combined input of 200 ng in each case.
We then selected a set of probes that were specific for the DFCI
#121 sample such that the detection p-value ,0.01 for DFCI
#121, but .0.01 for DFCI #123. Using these thresholds a set of
154 DFCI #121-specific probes were obtained. The average
signal intensities for this probe set in each mixture were calculated
and then compared to that obtained for the 100% DFCI #121
sample. With 82–98% of the DFCI #121-specific probes detected
in the 33–50% DFCI #121/123 mixtures, the WG-DASL assay
therefore is capable of detecting 1.5–2-fold changes in FFPE
samples (Fig. 3C).
The WG-DASL assay also yielded a dynamic range of ,3 logs
as determined by serial dilutions of artificially synthesized RNAs
spiked into a background of 100 ng total Raji RNA (Fig. S2).
Performance with Low Inputs
Having obtained robust expression profiling data with 100 ng
intact total RNA, we next sought to determine the performance of
the WG-DASL assay at lower RNA input levels. For this purpose
various amounts (100 ng, 50 ng, 10 ng, 5 ng, 1 ng, 250 pg, 100 pg
and 10 pg) of Raji and MCF-7 total RNAs were assayed. For both
RNA Profiling of FFPE Tissues
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reproducible expression profiles with an average correlation of
R
2,0.92 (Fig. 4A, Table 3), while the 50 pg and 10 pg RNA
inputs yielded average intensity correlations of R
2,0.82 and 0.78,
respectively (Table 3). On average, the probe overlap as compared
to 100 ng was 71.7%, 42.6% and 22.9% for the 250, 50 and 10 pg
inputs respectively (Table 3). Comparison of expression profiles
generated with the lower inputs to that obtained with the standard
100 ng input revealed average intensity correlations of R
2,0.91
for the 250 pg (Fig. 4B), and R
2,0.80 and 0.72 for the 50 pg and
10 pg inputs, respectively (Table 3). To further assess the ability
of the WG-DASL assay to detect differentially expressed genes
with lower inputs we compared lists of differentially expressed
transcripts detected at the 250 pg level to that obtained with
the standard 100 ng input. Using a p-value =0.001 cutoff,
approximately 95.5% (10716/11222 probes) of the differentially
expressed transcripts in the 250 pg input was also identified in the
standard 100 ng input (Fig. 4C).
To assess the performance of the WG-DASL assay with limiting
quantities of FFPE samples, we performed a similar experiment as
described for the intact samples, using two FFPE samples (DFCI
#120 and DFCI #129) with total RNA inputs as follows: 200 ng,
Figure 1. WG-DASL assay reproducibility with variable RNA inputs. Raw intensity scatterplots (all 24526 probes) are shown for WG-DASL
assay replicates (replicate 1, x-axis; replicate 2, y-axis) for (A) 200 ng total RNA derived from a formalin-fixed, paraffin-embedded (FFPE) ovarian tumor;
(B) 100 ng intact Raji RNA; and (C) 200 ng artificially degraded Raji RNA; (D) The fold-change correlation between intact (x-axis) and artificially
degraded (y-axis) cell line RNAs was calculated as the Log2 of the fold-change between the Raji and MCF-7 sample intensities. All detected probes
(Detection p-value ,0.01) are plotted.
doi:10.1371/journal.pone.0008162.g001
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twice. For both FFPE samples, inputs as low as 5 ng yielded
detected probe concordance (overlap) rates of .85% and raw
intensity correlations of R
2.0.85 when compared with standard
inputs of 200 ng (Table 1). Moreover, these results were
reproducible with self-correlations of R
2.0.90. Despite the lower
probe concordance rates (,60%) between the 1 ng input and the
standard 200 ng input, the raw expression profiles at the 1 ng
input level remained reproducible, with R
2,0.80 and had
correlations of R
2.0.75 when compared with the standard
200 ng input.
Comparison and Validation of the WG-DASL Assay with
IVT-Based Microarray Profiling and Real-Time
Quantitative PCR Methods
To validate the global expression profiles obtained with the
WG-DASL assay, 100 ng total RNA derived from MCF-7 and
Raji cells were labeled using an in vitro transcription (IVT)-based
method [22] and hybridized to the same microarray. The IVT-
method employed here allows linearly amplified cRNA to be
directly hybridized to the same type of whole genome expression
BeadChip as that used in the WG-DASL assay and provides
an independent means by which different labeling methods
may be compared on a global scale. Fold-change (i.e. Raji/
MCF-7) data derived from both the WG-DASL assay and
the IVT-method were then extracted and compared. Our analysis
yielded reproducible and highly similar results, with an average
correlation of R
2,0.80 (Fig. 5A), indicative of a high degree
of measurement concordance between the two different gene
expression platforms.
We also compared the WG-DASL assay results to that obtained
with real-time quantitative PCR (qRT-PCR). For comparisons in
intact RNAs we designed a set of primers corresponding to a panel
of 24 genes, whose expression levels differed between the assayed
cell lines (Raji and MCF-7). Using the ‘‘fold-change’’ method
described earlier, our comparisons across these 24 common genes
between the WG-DASL (100 ng input RNA) and the qRT-PCR
assays consistently demonstrated, on average, a strong correlation
(R
2,0.87) across replicate experiments (Fig. 5B). Furthermore, a
similar degree of concordance (R
2,0.85) was maintained even
when the WG-DASL assay was performed with 250 pg RNA input
(Fig. 5C). We noted a compression of the WG-DASL fold-change
data as compared to that obtained with the qRT-PCR assay – a
phenomenon that has been previously reported for microarray-
based expression analysis [9,23]. For comparisons in FFPE-
derived RNAs we designed a set of primers corresponding to a
panel of 12 genes, with amplicon sizes ranging from 70–85 bp. We
then compared WG-DASL and qRT-PCR data (Table S1)
obtained for three ovarian cancer FFPE samples (DFCI #79, 98
and 118). Across the 12 assayed genes we obtained fold-change
correlations of R
2=0.63 for DFCI #79/98, R
2=0.61 for DFCI
#98/118 and R
2=0.42 for DFCI #79/118, yielding an average
of R
2=0.55 for all three paired combinations.
Discussion
Over the last two decades, significant strides have been made in
RNA profiling in FFPE tissues, including efforts to standardize
tissue handling and fixation procedures [24,25] and improving
RNA extraction methodologies for FFPE tissues [13,26,27].
Despite these advancements, very few technologies have emerged
that are capable of robust whole transcriptome profiling in
archived FFPE materials. Initial attempts at large-scale expression
profiling in FFPE tissues yielded either poor reproducibility and
sensitivity [28] or loss of gene signature information when
Table 1. WG-DASL Assay Performance as a Function of FFPE RNA Input.
Metric 200 ng 50 ng 10 ng 5 ng 1 ng 250 pg
Average number of detected probes (DFCI #120) 19066 18393 18152 17627 12742 6079
Average number of detected probes (DFCI #129) 18031 17677 17113 16404 10998 5585
Average probe overlap with 200 ng (DFCI #120; %) 100.0 93.6 91.0 88.7 63.7 30.8
Average probe overlap with 200 ng (DFCI #129; %) 100.0 95.7 90.8 87.3 60.5 30.8
Average correlation with 200 ng (DFCI #120; R
2) 100.0 0.951 0.920 0.895 0.794 0.636
Average correlation with 200 ng (DFCI #129; R
2) 100.0 0.957 0.903 0.873 0.748 0.398
Self-Reproducibility (DFCI #120; R
2) 0.987 0.965 0.959 0.935 0.800 0.724
Self-Reproducibility (DFCI #129; R
2) 0.986 0.979 0.958 0.940 0.803 0.680
Values for the number of detected probes, probe overlap and correlation are derived from the average of two technical replicates. Probe overlap is calculated as a
percentage of the number of probes with matching detected calls at p-value ,0.01 between the low and standard inputs divided by the total number of probes
detected in the standard input (200 ng). Values shown for the correlation and self-reproducibility are calculated for probes detected (p ,0.01) in both inputs and
replicates, respectively.
doi:10.1371/journal.pone.0008162.t001
Table 2. WG-DASL Assay Performance with Intact and
Artificially Degraded RNA Inputs.
Metric
Intact
MCF-7
Intact
Raji
Degraded
MCF-7
Degraded
Raji
Average number of
detected probes
15247 13291 14535 12675
Average probe overlap
with intact RNA (%)
100.0 100.0 93.5 94.2
Probe concordance (%) 97.6 98.2 94.8 97.1
Self-Reproducibility (R
2) 0.988 0.990 0.982 0.988
Values for the number of detected probes and probe overlap are derived from
the average of two technical replicates. Probe overlap is calculated as a
percentage of the number of probes with matching detected calls at p-value ,
0.01 between the artificially degraded and intact inputs divided by the total
number of probes detected in the intact samples. Values shown for self-
reproducibility are calculated for probes detected (p ,0.01) in both replicates.
Artificially degraded RNA was generated by heating intact RNA at 95uCf o r
30 min.
doi:10.1371/journal.pone.0008162.t002
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commercial and academic endeavors have focused on improving
the efficiency of amplification and labeling of FFPE-derived RNAs
and have met with varying degrees of success [5–8,30–34]. While
in some instances these technologies have demonstrated their
ability to retrieve meaningful biological information from
degraded samples [27,35], concerns remain centered largely
around the capability with which older archived tissues (.10
years) can be routinely profiled [29,31] as well as reports of low
signal intensities and poor (transcript) detection sensitivity in FFPE
tissues [5,7,36].
Here we describe the development of a robust and highly
sensitive profiling assay capable of generating high quality
expression profiles in degraded/FFPE samples at a whole-
transcriptome level. The assay is highly reproducible with as little
as 50 ng total RNA extracted from FFPE tissues (R
2.0.97). It is
capable of accurately detecting 1.3–1.5 and 1.5–2 fold changes in
intact and FFPE samples, respectively, with a dynamic range of 3
Figure 2. Comparison between fresh-frozen (FF) and FFPE samples. Matched FF and FFPE samples for lung tumor (TUM) and normal
adjacent tissue (NAT) were labeled and hybridized using the WG-DASL assay. (A) Assays were performed in quadruplicate and the average number of
detected probes plotted for each sample (error bars 6 SEM). (B) The overlap of detected probes between the matched FF and FFPE samples for both
the NAT and TUM tissues was calculated as the percentage of detected FFPE probes also detected in the corresponding FF sample. (C) The fold-
change correlation between FF and FFPE samples was calculated as the Log2 of the fold-change between the NAT and TUM tissues intensities. All
detected probes (Detection p-value ,0.01) are plotted. (D) Lists of differentially expressed probes were generated by comparing replicates of the
NAT and TUM tissues with a false discovery rate (FDR) cutoff of ,5%. The overlap of differentially expressed probes between the FF and FFPE
matched samples for both the NAT and TUM tissues was calculated as the percentage of differentially expressed FFPE probes also detected in the
corresponding FF sample.
doi:10.1371/journal.pone.0008162.g002
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a high degree of profile concordance with a large number of
transcripts robustly detected in both FF and FFPE samples.
Detailed comparisons between normal and tumor FF and FFPE
sample sets yielded significant fold-change correlations of R
2,0.70
and .70% of the differentially expressed transcripts shared
between both FF and FFPE sample sets. For qRT-PCR vs. WG-
DASL comparisons we, like others [5], also noted poorer
correlations for genes with low array signal intensities, which
adversely impacted the overall platform concordance. Despite this
effect we obtained an average fold-change correlation of
R
2=0.55, a result which is consistent with that reported for other
Figure 3. Assay fold-change detection. (A) Total RNAs from Raji (R) and MCF-7 (M) cells were mixed at various ratios, with each mixture having a
combined input of 100 ng. After labeling and hybridizing, the raw data underwent unsupervised hierarchical clustering using all 24526 probes shown
in the cluster dendrogram. Units on the x-axis are Pearson’s correlation coefficient (R). (B) Using a set of differentially expressed probes, derived from
comparisons between the two intact RNA samples (Raji and MCF-7), the number of differentially expressed probes identified in different Raji/MCF-7
mixtures was calculated and plotted as a percentage of that identified in the 100% Raji sample. Values on the x-axis correspond to the percentage of
Raji RNA in each mixture, while the values on the y-axis represent the percentage of Raji-specific probes detected in each mixture at p ,0.05. For
example, more than 98% of the Raji-specific probes were detected in the 25% Raji mixture (1.3-fold change) and higher Raji mixtures. (C) Using a set
of differentially expressed probes, obtained from comparisons between two FFPE samples (DFCI #121 and DFCI #123), the number of differentially
expressed probes identified in the different DFCI #121/#123 mixtures was calculated and plotted as a percentage of that identified in the 100% DFCI
#121 sample. Values on the x-axis correspond to the percentage of DFCI #121 RNA in each mixture, while the values on the y-axis represent the
percentage of DFCI #121-specific probes detected in each mixture at p,0.05. For example, more than 80% of the DFCI #121-specific probes were
detected in the 33% DFCI #121 mixture (1.5-fold change) and higher DFCI #121 mixtures.
doi:10.1371/journal.pone.0008162.g003
RNA Profiling of FFPE Tissues
PLoS ONE | www.plosone.org 6 December 2009 | Volume 4 | Issue 12 | e8162Figure 4. WG-DASL assay performance with low RNA inputs. (A) Raw intensity scatterplots are shown for assay replicates for 250 pg Raji RNA
and (B) also for a correlation between 250 pg and 100 ng Raji RNA. (C) Lists of differentially expressed probes were generated by comparing replicate
data for Raji and MCF-7 cells using a cutoff of p=0.001. The overlap of differentially expressed probes (Raji vs. MCF-7) between the 250 pg and
100 ng RNA inputs was calculated as the percentage of differentially expressed probes identified in the 250 pg sample which was also identified in
the 100 ng sample.
doi:10.1371/journal.pone.0008162.g004
Table 3. WG-DASL Assay Performance as a Function of Intact RNA Input.
Metric 100 ng 50 ng 10 ng 5 ng 1 ng 250 pg 50 pg 10 pg
Average number of detected probes (MCF-7) 15247 15150 15060 14966 14279 10382 6671 3258
Average number of detected probes (Raji) 13291 13141 13032 13001 12197 10001 5499 3254
Average probe overlap with 100 ng (MCF-7; %) 100.0 99.4 98.8 98.2 93.7 68.1 43.8 21.4
Average probe overlap with 100 ng (Raji; %) 100.0 98.9 98.1 97.8 91.8 75.2 41.4 24.5
Average correlation with 100 ng (MCF-7; R
2) 1.000 0.986 0.976 0.966 0.932 0.906 0.795 0.717
Average correlation with 100 ng (Raji; R
2) 1.000 0.988 0.976 0.971 0.920 0.917 0.807 0.729
Self-Reproducibility (MCF-7; R
2) 0.988 0.987 0.986 0.982 0.969 0.909 0.826 0.791
Self-Reproducibility (Raji; R
2) 0.990 0.989 0.987 0.986 0.941 0.921 0.821 0.775
Values for the number of detected probes, probe overlap and correlation are derived from the average of two technical replicates. Probe overlap is calculated as a
percentage of the number of probes with matching detected calls at p-value ,0.01 between the low and standard inputs divided by the total number of probes
detected in the standard input (100 ng). Values shown for the correlation and self-reproducibility are calculated for probes detected (p ,0.01) in both inputs and
replicates, respectively.
doi:10.1371/journal.pone.0008162.t003
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DASL assay now enables studies that previously would have been
difficult, for example, using archival tissue blocks for either
retrospective or prospective randomized trials. Indeed, it has
already been successfully applied to interrogate global gene
expression patterns in stage I serous invasive versus borderline
ovarian tumors [37].
In addition to enabling whole-genome RNA profiling in FFPE
tissues, the WG-DASL assay also performs well with low RNA
inputs. With as little as 250 pg of intact total RNA (,25 cell
equivalent), the assay still maintains good reproducibility
(R
2=0.92) without significantly compromising either the intensity
correlation (R
2=0.91), sensitivity (.70%) or differential transcript
overlap (.85%) when compared with standard amounts of RNA
input (100 ng). For FFPE-derived RNAs, inputs as low as 1 ng
total RNA generated reproducible expression profiles with
R
2,0.80, while still maintaining a correlation of R
2,0.75 when
compared with standard FFPE inputs (200 ng). Therefore, this
technology is particularly useful for clinical research where
minimally invasive procedures often yield limiting amounts of
starting material such as fine needle biopsies and circulating tumor
cells.
Figure 5. Validation with in vitro transcription-based and qRT-PCR assays. (A) Logarithmic fold-changes in transcript abundance between
two cancer cell lines (Raji and MCF-7) were compared between the WG-DASL assay (100 ng total RNA input; x-axis) and an in vitro transcription (IVT)-
based array platform (100 ng total RNA input; y-axis); data were quantile normalized and all common detected probes (Detection p-value ,0.01)
were plotted. (B) Comparison of the WG-DASL assay (100 ng total RNA input; x-axis) and qRT-PCR (y-axis) with intact RNA and (C) the WG-DASL assay
with lower intact input (250 pg total RNA; x-axis) and qRT-PCR (y-axis). The qRT-PCR fold-change data are derived from Ct values for 24 common
transcripts.
doi:10.1371/journal.pone.0008162.g005
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RNA Samples
Cancer cell line RNAs, breast adenocarcinoma (MCF-7) and
Burkitts Lymphoma (Raji), were purchased from Applied
Biosystems Inc/Ambion (Austin, TX, USA). For comparisons
between fresh frozen and FFPE tissues we used matched lung
tissue samples from a tumor and the normal adjacent tissue that
were preserved as fresh-frozen and FFPE tissue. RNA was
extracted from the fresh frozen tissue using a standard RNeasy
protocol (QIAGEN GmbH, Hilden, Germany), while FFPE RNAs
were isolated from 10 mm sections using the FormaPure Kit
(Agencourt Bioscience Corporation, Beverly, MA, USA). The
archival age for the lung FFPE tissues was 3 years. RNAs from
ovarian tumor FFPE samples, with archival ages ranging from
8–13 years, were extracted using the RNeasy FFPE Kit (QIAGEN
GmbH, Hilden, Germany) according to the manufacturer’s
instructions with a few modifications described next. Punch
biopsies (3–4), 0.6 mm in diameter, were obtained from each
tissue block and were placed in a tube containing 1 ml xylene.
Immediately after the 100% ethanol extraction step, an additional
70% ethanol extraction was performed. Proteinase K digestions
were at 55uC for 35 min followed by 80uC for 25 min. Genomic
DNA was removed by centrifugation in gDNA Eliminator spin
columns at 8000 x g for 1 min, after which a volume of 1400 ml
ethanol was added to the flow-through fraction, resulting in three
passes through the RNeasy MinElute spin column. The first Buffer
RPE wash was performed at 8000 x g for 1 min and prior to the
final elution the dried spin column membranes were incubated in
30 ml RNase-free water for 10 min at room temperature before
centrifugation.
Whole Genome DASL Assay Workflow
The Whole-Genome DASL assay is derived from a previously
described high throughput gene expression system, the cDNA-
mediated annealing, selection, extension and ligation (DASL)
assay [9], but differs from the original assay by having improved
multiplexing capability, thereby significantly increasing the
number of transcripts that may be assayed in parallel, while still
retaining the ability to profile degraded samples. Briefly, total
RNA was converted to cDNA using biotinylated oligo-dT18 and
random nonamer primers. Two assay-specific oligonucleotides
were designed to interrogate a single contiguous 50 nt sequence on
each cDNA. Each of these oligonucleotides consisted of two parts:
an upstream-specific oligonucleotide (USO) containing a 39 gene-
specific sequence and a 59 universal PCR primer sequence (P1),
while the downstream-specific oligonucleotide (DSO) contained a
59 gene-specific sequence and a different 39 universal PCR primer
sequence (P29). The USOs and DSOs were designed with an
average Tm of 65uC and 58uC, respectively and an average length
of 22 and 20 nt, respectively. Using this approach, a total of 24526
oligonucleotide pairs (probes) were designed and pooled, which
together constituted the whole genome DASL assay pool (DAP),
corresponding to 18626 unique genes, based on well-annotated
content derived from the National Center for Biotechnology
Information Reference Sequence Database (Build 36.2, Release
22)). The DAP was then annealed to the targeted cDNAs during a
16 h temperature gradient (70 to 30uC) incubation followed by
enzymatic extension and ligation steps, as previously described [9].
Ligated products were PCR-amplified and labeled with a universal
Cy3-coupled primer after which single-stranded labeled products
were precipitated and then hybridized to whole genome gene
expression BeadChips as previously described [22]. BeadChips
were then scanned on a BeadArray
TM Reader using BeadScan
software (v3.2), during which fluorescence intensities were read
and images extracted. Scanned data were then uploaded into
GenomeStudioH software (v1.1), via the gene expression module
(WG-DASL Assay) for further analysis. All of the microarray data
are MIAME compliant and have been submitted to GEO
(Accession Number: GSE17599).
Microarray Data Analysis
Unless otherwise stated, all data were analyzed in an un-
normalized, raw state. All individual samples were assayed a
minimum of two times and in certain instances as many as six
replicates were performed. Data quality was assessed using several
assay controls and Detection p-values were computed using several
hundred negative controls to determine gene expression detection
limits. Unsupervised hierarchical clustering was performed in
GenomeStudio using Pearson’s correlation coefficient and average
linkage clustering. Assay performance metrics are described
further in the Results section.
Real-Time Quantitative RT-PCR (qRT-PCR)
Total RNAs were converted to cDNA using the WG-DASL
assay workflow described earlier. For quantifying intact RNAs, a
set of 24 primers was used to amplify approximately 200 bp
fragments, while for FFPE-derived RNAs a set of 12 primers was
designed to generate 70–85 bp amplicons. qRT-PCR analyses
were performed on the ABI Prism 7900HT sequence detection
system (Applied Biosystems Inc, Foster City, CA, USA) as
described previously [9]. In brief, reactions contained 1 ml cDNA
template (the equivalent of 1 ng intact RNA or 2 ng FFPE-derived
RNA obtained from a serial dilution of the original WG-DASL
assay-derived cDNA), 0.25 mM each of forward and reverse
primer (Invitrogen, Carlsbad, CA, USA) and 5 ml SYBR Green
PCR Master Mix (Applied Biosystems Inc, Foster City, CA, USA)
in a total volume of 10 ml. PCR amplifications consisted of an
initial enzyme activation step at 95uC for 12 min followed by 40
cycles of 95uC for 20 sec, 54uC for 20 sec and 72uC for 30 sec.
Supporting Information
Figure S1 Differential gene expression overlap between FF and
FFPE samples at FDR ,1%. Lists of differentially expressed
probes were generated by comparing replicates of the NAT and
TUM tissues with a false discovery rate (FDR) cutoff of ,1%. The
overlap of differentially expressed probes between the FF and
FFPE matched samples for both the NAT and TUM tissues was
calculated as the percentage of differentially expressed FFPE
probes also detected in the corresponding FF sample.
Found at: doi:10.1371/journal.pone.0008162.s001 (6.76 MB TIF)
Figure S2 WG-DASL assay dynamic range. Intensity data from
eight synthetic RNAs are shown as the number of input RNA
molecules (x-axis) vs. log10 intensity (y-axis). Experiments were
performed in duplicate and the error bars were calculated as the
standard error of the mean.
Found at: doi:10.1371/journal.pone.0008162.s002 (6.76 MB TIF)
Table S1 qRT-PCR and WG-DASL Assay Data for FFPE
Tissues.
Found at: doi:10.1371/journal.pone.0008162.s003 (0.07 MB
DOC)
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